PROSPECTS OF USING NEW GENERATION DRUGS IN THE COMPREHENSIVE TREATMENT OF BLEPHARITIS
DOI:
https://doi.org/10.34132/mspc2025.01.08.25Keywords:
Blepharitis, inflammation, autologous platelet cryoconcentrate, oxidative stress, antioxidant activity, tear fluid, conservative treatmentAbstract
The thesis presents an analysis of literary sources regarding the effectiveness of using therapeutic agents and preventing the development of complications in inflammation of the anterior segment of the eye - blepharitis. It is emphasized that concomitant diseases, including diabetes, contribute to the development of complications in case of untimely treatment. The use of autologous platelet cryoconcentrate in the complex therapy of bacterial blepharitis normalized the clinical manifestations of blepharitis in the absence of disease recurrence. It is emphasized that the use of autocryothrombolysis in the complex therapy of animals with blepharitis against the background of concomitant diseases can be recommended for widespread use in clinical practice.
References
Amescua, G., Akpek, E.K., Farid, M., Garcia-Ferrer, F.J., Lin, A., Rhee M.K., …Mah F.S. (2019). American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel. Blepharitis Preferred Practice Pattern. Ophthalmology, 126(1), (pp. 40-44).
Page, M.R. (2024). Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives. J Manag Care Spec Pharm, 30(10-a Suppl), (pp. 1-8).
Eberhardt, M., Zeppieri, M., & Rammohan, G. Blepharitis. (2025). In: StatPearls [Internet], Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459305/.
Sakimoto, T., & Sugiura, T. (2023). Clinical features of anterior blepharitis after cataract surgery. Sci Rep, 13, 6615. https://doi.org/10.1038/s41598-023-33956-9.
Pflugfelder, S.C., Karpecki, P.M., & Perez ,V.L. (2014). Treatment of blepharitis: recent clinical trials. Ocul Surf, 12(4), (pp. 273-284).
Dias, M.R., Guaresch, B.L.V., Borges, C.R., Biazim, D.F., Casagrande, D., & Luz, R.A. (2019). Blepharitis: epidemiology, etiology, clinical presentations, treatment and evolution of our patients. Rev Bras Oftalmol, 78 (5), (pp. 300-303).
Afzal, M., Vijay, A.K., Stapleton, F., & Willcox, M.D.P. (2021). Susceptibility of Ocular Staphylococcus aureus to Antibiotics and Multipurpose Disinfecting Solutions. Antibiotics (Basel), 10(10), 1203. doi: 10.3390/antibiotics10101203.
Patil, R., Dehari, D., Chaudhuri, A., Kumar, D.N., Kumar, D., & Singh, S., …Agrawal, A.K. (2023). Recent advancements in nanotechnology-based bacteriophage delivery strategies against bacterial ocular infections. Microbiol Res, 273:127413. doi: 10.1016/j.micres.2023.127413.
Cieślik-Bielecka, A., Bold, T., Ziółkowski, G., Pierchała, M., Królikowska, A., & Reichert, P. (2018). Antibacterial Activity of Leukocyte- and Platelet-Rich Plasma: An In Vitro Study. Biomed Res Int, 9471723. doi: 10.1155/2018/9471723.
Tsepkolenko, V.O, Pshenychnyi, Т.Y., Holiuk, Ye.L, Tymochuk, V.V., & Derkach R. V. (2021). Vykorystannia automezokontsentratu trombotsytiv u patsiientiv z patolohiieiu oporno-rukhovoho aparatu [The Platelet Automesoconcentrate in Patients with Orthopedical Pathology]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu – Ukrainian Journal of Medicine, Biology and Sports, 6(11), (pp. 160-167) [in Ukrainian].
Merolle, L., Iotti, B., Berni, P., Bedeschi, E., Boito, K., Maurizi, E., …Schiroli, D. (2022). Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases. J Vis Exp, 186. doi: 10.3791/63772.
Troha, K., Vozel, D., Arko, M., Bedina Zavec, A., Dolinar, D., Hočevar, M., …Kralj-Iglič, V. (2023). Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review. Int J Mol Sci,24(4), 3420. doi: 10.3390/ijms24043420.
Akeda, K., Yamada, J., Linn, E.T., Sudo, A., & Masuda, K. (2019). Platelet-rich plasma in the management of chronic low back pain: a critical review. J Pain Res,12, (pp. 753–767). doi: 10.2147/JPR.S153085.
Nurden, A.T. (2011). Platelets, inflammation and tissue regeneration. Thromb Haemost, 105(Suppl 1), (pp. 13–33). doi: 10.1160/THS10-11-0720.
